Syndax Pharmaceuticals
Clinical trials sponsored by Syndax Pharmaceuticals, explained in plain language.
-
New drug tested for tough transplant complication
Disease control CompletedThis study tested an experimental drug called axatilimab for people with chronic graft-versus-host disease (cGVHD) that hadn't improved after at least two previous treatments. The trial aimed to find a safe dose and see if the drug could help control the disease. It involved 41 p…
Phase: PHASE1, PHASE2 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New drug tested for Tough-to-Treat cancers after standard therapies fail
Disease control CompletedThis early-phase study tested a new oral drug called revumenib (SNDX-5613) in 42 adults with advanced colorectal cancer or other solid tumors that had worsened despite at least one prior treatment. The main goals were to find a safe dose, see how the body processes the drug, and …
Phase: PHASE1, PHASE2 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC